Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This months Patent Gazette features Dunads covalent PIKfyve inhibitors, Storm Therapeutics DHX9 inhibitors, and Monte Rosas CCNE1 molecular glue degraders for biomarker-defined cancers
COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation
Int J Transl Med
Clinical Endocrinology
Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats
44 , D1251D1257 (2016)
US$ 22.69
US$ 29.12
US$ 26.31
US$ 23.72
